About this episode
When Ontario and Alberta decided they would stop giving the AstraZeneca vaccine as a first dose, part of the reasoning was an abundant supply of other vaccines. But that feels like cold comfort to Canadians who eagerly lined up because "the best shot you can get is the one in your arm" and now might be feeling scared or ripped off. What options do those Canadians have? Another vaccine for a second dose? To wait and see? What can those of us who have one dose of any vaccine do in between our shots? Could any of this have been avoided, or is it just a case of the science changing?
GUEST: Sabina Vohra-Miller, clinical pharmacologist
We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:
Through email at [email protected]
Or @thebigstory.bsky.social on Bluesky
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time The Big Story publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Big Story
Big Headlines: Canada's counter-tariffs against the U.S. are now in effect as Ca...
The Big Story
How economic hardship increases gender-based violence
The Big Story
Weekend Listen: The US energy trade battle: Canada vs. Venezuela
The Big Story
Big Headlines: Montreal college resumes classes after some uncertainty over its...
The Big Story